Director, Clinical Trials Regulatory
IQVIA
Chris Bamford PhD is a Director of Clinical Trials Regulatory Affairs in the IQVIA Clinical Trials Regulatory Management (CTRM) team. He has represented IQVIA and ACRO in EMA Stakeholder groups relating to the development and implementation of the EU CTR and CTIS since 2014. This has enabled IQVIA to support pharmaceutical companies in developing processes and adapting roles and responsibilities in relation to the new Regulation, including incorporation of newly-required aspects such as redaction and an understanding of the CTIS user management framework. More broadly Chris has been a leader within the IQVIA CTRM team in relation to all aspects of clinical trial regulatory affairs, in addition to engaging with cross-industry working groups in relation to the implementation of regulatory changes such as revisions to ICH guidelines, EU guidance and national regulations.
Chris has a PhD in molecular biology and has worked in academic research settings and biotechnology companies before joining the Quintiles Regulatory Affairs team in 2009.
Disclosure information not submitted.
Unveiling Insights: Navigating the Public Disclosure of Clinical Trials in an Evolving Industry
Tuesday, May 7, 2024
13:45 – 14:45 CEST